result in the expenditure of resources that could more usefully be applied to reduce other pollutants. For these and other reasons, a fuller characterization and understanding of the biological effects of low-level exposures (BELLE) will enable the U.S. EPA to better serve its mission.
When assessing health risks U.S. EPA scientists consider information on the mechanisms of toxicity when such information is available, as illustrated by the role of alpha2u-microglobulin in producing male rat kidney tumors and by the existence of nongenotoxic carcinogens. However, as the U.S. EPA's 1996 proposed cancer guidelines (1) indicate, it is important to think more broadly than the mechanism; that is, one must consider the mode of action, which encompasses all relevant mechanisms as well as other factors that contribute to an agent's influence on 
